Zeenat Qureshi Stroke Research Center, University of Minnesota, 420 Delaware St SE, MMC 295, Minneapolis, MN 55455, USA.
Stroke. 2013 Jun;44(6):1601-5. doi: 10.1161/STROKEAHA.111.000590. Epub 2013 Apr 30.
Approximately 70% of all patients presenting with transient ischemic attack are admitted to the hospital in United States. The duration and cost of hospitalization and associated factors are poorly understood. This article seeks to identify the proportion and determinants of prolonged hospitalization and to determine the impact on hospital charges using nationally representative data.
We determined the national estimates of length of stay, mortality, and charges incurred in patients admitted with transient ischemic attack (diagnosis-related code 524 or 069) using Nationwide Inpatient Sample data from 2002 to 2010. Nationwide Inpatient Sample is the largest all-payer inpatient care database in the United States and contains data from ≈1000 hospitals, which is a 20% stratified sample of US community hospitals. All the variables pertaining to hospitalization were compared in 3 groups on the basis of length of hospital stay (≤ 1, 2-6, and ≥ 7 days).
A total of 949 558 patients were admitted with the diagnosis of transient ischemic attack during the study period. The length of hospitalization was ≤ 1, 2 to 6, and ≥ 7 days in 232 732 (24.4%), 662 909 (70%), and 53 917 (5.6%) patients, respectively. The mean hospitalization charges were $10 876, $17 187, and $38 200 for patients hospitalized for ≤ 1, 2 to 6, and ≥ 7 days, respectively. The use of thrombolytics (0.03%, 0.09%, and 0.1%; P<0.0001) for ischemic stroke was very low among the 3 strata defined by length of hospitalization. In the multivariate analysis, the following factors were associated with length of hospitalization of ≥ 2 days: age >65 years (odds ratio [OR], 1.5), women (OR, 1.2), admission to teaching hospitals (OR, 1.1), renal failure (OR, 1.7), hypertension (OR, 1.1), diabetes mellitus (OR, 1.2), chronic lung disease (OR, 1.4), congestive heart failure (OR, 1.4), atrial fibrillation (OR, 1.5), ischemic stroke occurrence (OR, 1.4), Medicare/Medicaid insurance (OR, 1.3), and hospital location in Northeast US region (OR, 1.5; all P values <0.025).
Approximately 75% of patients admitted with transient ischemic attack stay in the hospital for ≥ 2 days, with the most important determinants being pre-existing medical comorbidities. Longer duration of hospital stay is associated with 2- to 5-fold greater hospitalization charges.
在美国,约 70%的短暂性脑缺血发作患者会住院治疗。住院时间和费用及其相关因素尚不清楚。本文旨在利用全国代表性数据,确定延长住院时间的比例和决定因素,并确定对住院费用的影响。
我们使用 2002 年至 2010 年全国住院患者样本(NIS)数据,确定短暂性脑缺血发作患者(诊断相关代码 524 或 069)的住院时间、死亡率和费用的全国估计值。NIS 是美国最大的所有支付者住院护理数据库,包含来自约 1000 家医院的数据,这是美国社区医院的 20%分层样本。根据住院时间(≤1、2-6 和≥7 天),将与住院相关的所有变量在 3 组中进行比较。
在研究期间,共有 949558 例患者被诊断为短暂性脑缺血发作。住院时间分别为≤1、2-6 和≥7 天的患者分别为 232732(24.4%)、662909(70%)和 53917(5.6%)。住院≤1、2-6 和≥7 天的患者的平均住院费用分别为 10876、17187 和 38200 美元。在根据住院时间定义的 3 个分层中,溶栓治疗缺血性卒中的使用率(0.03%、0.09%和 0.1%;P<0.0001)非常低。多变量分析显示,以下因素与住院时间≥2 天有关:年龄>65 岁(比值比[OR],1.5)、女性(OR,1.2)、入住教学医院(OR,1.1)、肾衰竭(OR,1.7)、高血压(OR,1.1)、糖尿病(OR,1.2)、慢性肺病(OR,1.4)、充血性心力衰竭(OR,1.4)、心房颤动(OR,1.5)、缺血性卒中(OR,1.4)、医疗保险/医疗补助保险(OR,1.3)和美国东北部地区医院位置(OR,1.5;所有 P 值均<0.025)。
约 75%的短暂性脑缺血发作患者住院时间≥2 天,最重要的决定因素是预先存在的合并症。住院时间延长与住院费用增加 2 至 5 倍有关。